Navigation Links
BioTrends Releases Fourth Annual Nephrology TreatmentTrends Publication Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
Date:1/28/2008

non-calcium agents (such as Genzyme's Renagel and Shire's Fosrenol) continues, with Renagel maintaining its position as market leader. While perceived need for a new phosphate binder is high, knowledge of new binders in development is low. Genzyme recently received approval for Renvela (sevelamer carbonate) which is expected to launch in the first quarter of 2008.

In the management of secondary hyperparathyroidism, nephrologists report an increased use of Vitamin D in both the dialysis and CKD populations which has grown consistently since 2004. While the majority of nephrologists view Abbott's Zemplar and Genzyme's Hectorol as interchangeable, Zemplar continues to grow its share in dialysis and CKD, currently leading Hectorol in both markets. In dialysis patients, use of Amgen's Sensipar has also increased in the past year and nephrologists expect continued growth with share rising from 29% to 35% in the next three months. Sensipar, however, tends to be reserved for patients with PTH greater than 500 pg/dL, and is typically used in combination with Vitamin D.

About BioTrends Research Group, Inc.

BioTrends Research Group, Inc. (http://www.bio-trends.com) provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at (610) 363-3872 or http://www.bio-trends.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.


'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
2. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
3. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
4. ARUP Laboratories Releases ARUP Consult(R) 2.0
5. Rabobank Releases Annual North American Food & Agribusiness Outlook
6. National Nanotechnology Initiative releases new strategic plan
7. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
8. CellCyte Genetics Corp. Responds to Plaintiff Law Firm Press Releases
9. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
10. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
11. Dynatronics to Release Fourth Quarter and Year-end Results Friday, September 14, 2007; Conference Call set for 1:00 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)HOPKINTON, Mass., Dec. 3 Caliper Life Sciences, Inc. (Nasdaq: CALP ), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 softwa
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
...t in Unresponsiveness to Patient Safety & Sati...if., March 24 The American Society of Anesthesiol...cal Association (AMA). Both publish monthly educat...ctively) and express an agenda for patient safety ...n primarily (and legitimately) as political organi...
... Mass.--New research findings at MIT could lead to...n is possible with today,s standard silicon chips,...ystems that can transmit data much faster. , The ...l called graphene, a form of pure carbon that was ...titutions have already used the one-atom-thick lay...
...EW, Calif., March 23 Alexza Pharmaceuticals, Inc....ate presentation will be webcast live during the 1...stry Conference on Thursday, April 2, 2009 at 3:00...ast from the Millennium Broadway Hotel & Confe...ive presentation via the Web, please go to the dir...
Other Biology Technology:American Society of Anesthesiologists Primary Agenda Displayed Says Dr. Barry Friedberg of Cosmetic Surgery Anesthesia 2MIT: New material could lead to faster chips 2MIT: New material could lead to faster chips 3Alexza's Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference 2Alexza's Corporate Presentation to be Webcast at the Future Leaders in the Biotech Industry Conference 3
(Date:12/3/2009)Spanish researchers have measured CO2 levels for the past three years in the troposphere (lower atmosphere) over a sparsely inhabited rural area near Valladolid. The results, which are the first of th
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Explorers Bounty Contributing Charitable Bounty to Great Chefs of Los Angeles Event 60826 1Explorers Bounty Contributing Charitable Bounty to Great Chefs of Los Angeles Event 60826 2CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 1CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 2CEL SCI to Conduct First Clinical Study of Investigational LEAPS H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc 60824 3NeurogesX Reports Third Quarter 2009 Results 14751 1NeurogesX Reports Third Quarter 2009 Results 14751 2NeurogesX Reports Third Quarter 2009 Results 14751 3NeurogesX Reports Third Quarter 2009 Results 14751 4NeurogesX Reports Third Quarter 2009 Results 14751 5NeurogesX Reports Third Quarter 2009 Results 14751 6NeurogesX Reports Third Quarter 2009 Results 14751 7NeurogesX Reports Third Quarter 2009 Results 14751 8NeurogesX Reports Third Quarter 2009 Results 14751 9NeurogesX Reports Third Quarter 2009 Results 14751 10
...esearchers are on the verge of unleashing the powe...s and therapies, as decades of research begins to ...ogy,s best kept secrets, but is now attracting fas...e pharmaceutical industry in the quest for novel d...entially overcoming limitations and side effects o...
...Do mothers purposely expose their offspring to the... because it is widely accepted that exposure to ma...e negative impacts on offspring following birth. T...o happen, evolutionary physiologists Oliver Love a...o the maternally-derived stress hormone corticoste...
...A 20-strong -team of cloud and climate experts fro... will today set off for Chile to investigate how m...c are affecting climate and weather all round the ... to reduce some of the largest errors currently in...ctions of future climate change. , These immens...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2British scientists go cloud-hopping in the Pacific to improve climate predictions 2
Taq DNA Polymerase from QIAGEN
Microfluidic Power Supply from Major Science
Rabbit Anti-Synapsin II Polyclonal Antibody, Unconjugated from Abcam
...erts cloned into M13/pUC-based plasmids, plasmids ...ters, or lambda gt10 and gt11 vectors. They are su...n water. The primers are functionally tested in DN...L™ II DNA Polymerase with an end-labeled prim...
Biology Products: